Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Schiffmann

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
BJU International|March 12, 2014
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 5, 2014
Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapyJonas Schiffmann, Hans Lesmana, Pierre Tennstedt, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Medical management of benign prostatic hyperplasia: Results from a population-based studyMohamed Bishr, Katharina Boehm, Vincent Trudeau, et al.
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
The Journal of Urology|January 16, 2016
Limitations of Elastography Based Prostate BiopsyJonas Schiffmann, Mircea Grindei, Zhe Tian, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2016
Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare databaseJonas Schiffmann, Maxine Sun, Giorgio Gandaglia, et al.
The Prostate|October 18, 2013
Distribution of metastatic sites in patients with prostate cancer: A population-based analysisGiorgio Gandaglia, Firas Abdollah, Jonas Schiffmann, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
BJU International|March 12, 2014
The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based studyGiorgio Gandaglia, Maxine Sun, Ioana Popa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 5, 2014
Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapyJonas Schiffmann, Hans Lesmana, Pierre Tennstedt, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Medical management of benign prostatic hyperplasia: Results from a population-based studyMohamed Bishr, Katharina Boehm, Vincent Trudeau, et al.
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
The Journal of Urology|January 16, 2016
Limitations of Elastography Based Prostate BiopsyJonas Schiffmann, Mircea Grindei, Zhe Tian, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2016
Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare databaseJonas Schiffmann, Maxine Sun, Giorgio Gandaglia, et al.
The Prostate|October 18, 2013
Distribution of metastatic sites in patients with prostate cancer: A population-based analysisGiorgio Gandaglia, Firas Abdollah, Jonas Schiffmann, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
Pageof 6